{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:07:13Z","timestamp":1759410433688},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.12.038","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T09:08:42Z","timestamp":1262250522000},"page":"2088-2096","source":"Crossref","is-referenced-by-count":20,"title":["One time intranasal vaccination with a modified vaccinia Tiantan strain MVTTZCI protects animals against pathogenic viral challenge"],"prefix":"10.1016","volume":"28","author":[{"given":"Wenbo","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"July (2)","key":"10.1016\/j.vaccine.2009.12.038_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2009.12.038_bib2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccc.2005.06.004","article-title":"Smallpox","volume":"21","author":"Nafziger","year":"2005","journal-title":"Crit Care Clin"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.12.038_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0966-842X(00)01855-2","article-title":"The threat of smallpox and bioterrorism","volume":"9","author":"Berche","year":"2001","journal-title":"Trends Microbiol"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2009.12.038_bib4","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJM200204253461702","article-title":"Smallpox and bioterrorism","volume":"346","author":"Drazen","year":"2002","journal-title":"N Engl J Med"},{"issue":"December (50)","key":"10.1016\/j.vaccine.2009.12.038_bib5","doi-asserted-by":"crossref","first-page":"8359","DOI":"10.1016\/j.vaccine.2007.09.064","article-title":"Smallpox vaccination and ischemic coronary events in healthy adults","volume":"25","author":"Eckart","year":"2007","journal-title":"Vaccine"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.12.038_bib6","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1371\/journal.pmed.0030272","article-title":"Frequency of adverse events after vaccination with different vaccinia strains","volume":"3","author":"Kretzschmar","year":"2006","journal-title":"PLoS Med"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.12.038_bib7","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1128\/JVI.72.10.8264-8272.1998","article-title":"Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein","volume":"72","author":"Belyakov","year":"1998","journal-title":"J Virol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2009.12.038_bib8","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.12.038_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.nrl.0000138998.11209.88","article-title":"Anticipating smallpox and monkeypox outbreaks: complications of the smallpox vaccine","volume":"10","author":"Abrahams","year":"2004","journal-title":"Neurologist"},{"issue":"September (11)","key":"10.1016\/j.vaccine.2009.12.038_bib10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.290.11.1452-a","article-title":"Risks of smallpox vaccination","volume":"290","author":"Fulginiti","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2009.12.038_bib11","first-page":"562","article-title":"Characterization of the complete genomic sequence of the vaccinia virus Tiantan strain","volume":"27","author":"Jin","year":"1997","journal-title":"Sci China (Series)"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.038_bib12","first-page":"462","article-title":"Analysis of open reading frames located in Hind III-C and -B fragments of vaccinia virus strain Tiantan","volume":"10","author":"Jin","year":"1997","journal-title":"Biomed Environ Sci"},{"issue":"August (Pt 8)","key":"10.1016\/j.vaccine.2009.12.038_bib13","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1099\/0022-1317-83-8-1977","article-title":"Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes","volume":"83","author":"Tscharke","year":"2002","journal-title":"J Gen Virol"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2009.12.038_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","article-title":"Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tiantan strain","volume":"335","author":"Fang","year":"2005","journal-title":"Virology"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2009.12.038_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a non-human mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"issue":"April","key":"10.1016\/j.vaccine.2009.12.038_bib16","article-title":"The attenuation of vaccinia Tiantan strain by the removal of the viral M1L-K2L genes","author":"Zhu","year":"2007","journal-title":"J Virol Methods"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.12.038_bib17","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.66.5.2617-2630.1992","article-title":"Molecular attenuation of vaccinia virus: mutant generation and animal characterization","volume":"66","author":"Lee","year":"1992","journal-title":"J Virol"},{"issue":"November (Pt 11)","key":"10.1016\/j.vaccine.2009.12.038_bib18","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1099\/0022-1317-71-11-2761","article-title":"Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route","volume":"71","author":"Williamson","year":"1990","journal-title":"J Gen Virol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2009.12.038_bib19","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/JVI.74.9.4085-4092.2000","article-title":"The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses","volume":"74","author":"Betakova","year":"2000","journal-title":"J Virol"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2009.12.038_bib20","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.74.24.11654-11662.2000","article-title":"Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence","volume":"74","author":"Zhang","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.12.038_bib21","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Hygiene"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2009.12.038_bib22","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (6145)","key":"10.1016\/j.vaccine.2009.12.038_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/330259a0","article-title":"Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression","volume":"330","author":"Flexner","year":"1987","journal-title":"Nature"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.12.038_bib24","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/JVI.62.12.4474-4480.1988","article-title":"Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene","volume":"62","author":"Shida","year":"1988","journal-title":"J Virol"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2009.12.038_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2009.12.038_bib26","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Non-replicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (11)","key":"10.1016\/j.vaccine.2009.12.038_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0264-410X(94)90341-7","article-title":"A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus","volume":"12","author":"Sutter","year":"1994","journal-title":"Vaccine"},{"issue":"October (Pt 10)","key":"10.1016\/j.vaccine.2009.12.038_bib28","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1099\/0022-1317-67-10-2067","article-title":"Vaccinia virus expression vectors","volume":"67","author":"Mackett","year":"1986","journal-title":"J Gen Virol"},{"issue":"March (13)","key":"10.1016\/j.vaccine.2009.12.038_bib29","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June (5830)","key":"10.1016\/j.vaccine.2009.12.038_bib30","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.316.5830.1418","article-title":"Smallpox vaccine. A tame virus runs amok","volume":"316","author":"Kaiser","year":"2007","journal-title":"Science"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2009.12.038_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.virol.2005.01.006","article-title":"The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response","volume":"333","author":"Brandt","year":"2005","journal-title":"Virology"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2009.12.038_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.12.038_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/JVI.31.1.147-155.1979","article-title":"Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus","volume":"31","author":"Payne","year":"1979","journal-title":"J Virol"},{"issue":"March (Pt 3)","key":"10.1016\/j.vaccine.2009.12.038_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1099\/0022-1317-66-3-643","article-title":"Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo","volume":"66","author":"Payne","year":"1985","journal-title":"J Gen Virol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.12.038_bib35","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/j.1460-2075.1987.tb02660.x","article-title":"Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection","volume":"6","author":"Shida","year":"1987","journal-title":"Embo J"},{"issue":"October (1\u20132)","key":"10.1016\/j.vaccine.2009.12.038_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-1119(96)00267-3","article-title":"Characterization of the vaccinia MVA hemagglutinin gene locus and its evaluation as an insertion site for foreign genes","volume":"177","author":"Antoine","year":"1996","journal-title":"Gene"},{"issue":"August (Pt 8)","key":"10.1016\/j.vaccine.2009.12.038_bib37","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1099\/0022-1317-83-8-1965","article-title":"The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence","volume":"83","author":"Bartlett","year":"2002","journal-title":"J Gen Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.12.038_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/JVI.53.1.316-318.1985","article-title":"Mapping of a vaccinia host range sequence by insertion into the viral thymidine kinase gene","volume":"53","author":"Gillard","year":"1985","journal-title":"J Virol"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2009.12.038_bib39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0042-6822(90)90296-4","article-title":"Vaccinia virus host range genes","volume":"179","author":"Perkus","year":"1990","journal-title":"Virology"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2009.12.038_bib40","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1128\/JVI.00935-06","article-title":"Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells","volume":"80","author":"Gedey","year":"2006","journal-title":"J Virol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.12.038_bib41","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0042-6822(91)90158-8","article-title":"Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon","volume":"183","author":"Beattie","year":"1991","journal-title":"Virology"},{"issue":"June (17)","key":"10.1016\/j.vaccine.2009.12.038_bib42","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1016\/S0021-9258(18)31463-7","article-title":"Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase","volume":"268","author":"Carroll","year":"1993","journal-title":"J Biol Chem"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.12.038_bib43","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/JVI.67.3.1688-1692.1993","article-title":"K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms","volume":"67","author":"Davies","year":"1993","journal-title":"J Virol"},{"issue":"December (51)","key":"10.1016\/j.vaccine.2009.12.038_bib44","doi-asserted-by":"crossref","first-page":"39728","DOI":"10.1074\/jbc.M607465200","article-title":"The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax","volume":"281","author":"Taylor","year":"2006","journal-title":"J Biol Chem"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2009.12.038_bib45","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.vaccine.2005.03.029","article-title":"Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge","volume":"24","author":"Empig","year":"2006","journal-title":"Vaccine"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2009.12.038_bib46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2006.10.047","article-title":"Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals","volume":"25","author":"Parrino","year":"2007","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.12.038_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vaccine.2006.07.022","article-title":"Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine","volume":"25","author":"Phelps","year":"2007","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2009.12.038_bib48","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JVI.01854-07","article-title":"Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","volume":"82","author":"Berhanu","year":"2008","journal-title":"J Virol"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2009.12.038_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/518793","article-title":"Antibody responses to vaccinia membrane proteins after smallpox vaccination","volume":"196","author":"Lawrence","year":"2007","journal-title":"J Infect Dis"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2009.12.038_bib50","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0705191105","article-title":"Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic","volume":"105","author":"Corbett","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2009.12.038_bib51","first-page":"0A09","article-title":"A novel mucosal vacinia vector for inducing high level anti-viral immunity","volume":"11","author":"Chen","year":"2006","journal-title":"Antiviral Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.038_bib52","doi-asserted-by":"crossref","first-page":"e4180","DOI":"10.1371\/journal.pone.0004180","article-title":"A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination","volume":"4","author":"Huang","year":"2009","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T18:14:42Z","timestamp":1634667282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09019422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09019422"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}